Medium materiality6/10
Janux Therapeutics price target lowered to $55 from $58 at Guggenheim
Why it may matterVerify against the original reporting
bearish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Guggenheim lowers JANX price target to $55 from $58; current price $16.1.
- Guggenheim lowers JANX target to $55; price $16.1.
Key facts
- 01
Target: $55
- 02
Posted price: $16.1
- 03
Analyst firm: Guggenheim
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.